Kazia Therapeutics
KZIA
8 hedge funds and large institutions have $527K invested in Kazia Therapeutics in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 5 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0% more ownership
Funds ownership: 0% → 0.01% (+0%)
27% less funds holding
Funds holding: 11 → 8 (-3)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
57% less capital invested
Capital invested by funds: $1.24M → $527K (-$708K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$374K |
| 2 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$181K |
| 3 |
VF
Virtu Financial
New York
|
+$27.5K |
| 4 |
Morgan Stanley
New York
|
+$6.37K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$3.13K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Envestnet Asset Management
Chicago,
Illinois
|
-$111K |
| 2 |
SG Americas Securities
New York
|
-$59K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$50.9K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$29.1K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $224K | +$6.37K | +57 | +1% |
|
|
2
Acadian Asset Management
Boston,
Massachusetts
| $183K | +$374K | +3,348 | New |
|
|
OMC
3
Old Mission Capital
Chicago,
Illinois
| $89K | +$181K | +1,618 | New |
|
|
VF
4
Virtu Financial
New York
| $14K | +$27.5K | +246 | New |
|
|
TSS
5
Two Sigma Securities
New York
| $13K | -$29.1K | -260 | -53% |
|
|
6
UBS Group
Zurich,
Switzerland
| $4K | +$3.13K | +28 | +57% |
|
|
7
Envestnet Asset Management
Chicago,
Illinois
| – | -$111K | -528 | Closed |
|
|
8
Citadel Advisors
Miami,
Florida
| – | -$50.9K | -455 | Closed |
|
|
9
SG Americas Securities
New York
| – | -$59K | -280 | Closed |
|
|
10
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$4K | -20 | Closed |
|
11
Simplex Trading
Chicago,
Illinois
| – | -$4K | -20 | Closed |
|
KZIA Hedge Fund Activity: Q3 2022 in Review
8 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Kazia Therapeutics (KZIA) for Q3 2022, worth a combined $527K — down 57% from $1.24M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of KZIA and 3 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Acadian Asset Management, opening a new position worth an estimated $374K. The largest seller was Envestnet Asset Management, exiting entirely with an estimated $111K sold.
- 8 institutional investors held Kazia Therapeutics (KZIA) as of Q3 2022, down from 11 in Q2 2022.
- Funds reported $527K of Kazia Therapeutics stock for Q3 2022, down 57% quarter-over-quarter.
- 3 funds opened new Kazia Therapeutics positions in Q3 2022 and 5 closed out, a net change of -2 holders.
- The largest Kazia Therapeutics buyer in Q3 2022 was Acadian Asset Management, an estimated $374K added.
- The largest Kazia Therapeutics seller in Q3 2022 was Envestnet Asset Management, an estimated $111K sold.
Based on aggregated 13F filings for Q3 2022.